Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00606866
What this trial is testing

MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Chicago 57
Testing effectiveness (Phase 2)Study completedNCT02060370
What this trial is testing

Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)

Who this might be right for
Genitourinary CancerKidney Cancer
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00003584
What this trial is testing

Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of New Mexico 35
Not applicableStudy completedNCT01542333
What this trial is testing

Studying Biomarkers in Samples From Younger Patients With Wilms Tumor

Who this might be right for
Kidney Cancer
Children's Oncology Group 20
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Not applicableLooking for participantsNCT05548621
What this trial is testing

A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)

Who this might be right for
Renal Cell CarcinomaRenal Cell Carcinoma Metastatic
St. Antonius Hospital 180
Not applicableStudy completedNCT06171945
What this trial is testing

Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors

Who this might be right for
CancerPhysical ActivityCancer Survivorship+2 more
UNC Lineberger Comprehensive Cancer Center 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07077083
What this trial is testing

CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)ccRCC
Massachusetts General Hospital 10
Not applicableWithdrawnNCT01401777
What this trial is testing

Electromagnetic Tracking of Devices During Interventional Procedures - A Cryoablation Study

Who this might be right for
Kidney Tumors
Philips Healthcare
Early research (Phase 1)Active Not RecruitingNCT05783622
What this trial is testing

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more
Janux Therapeutics 130
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Early research (Phase 1)Active Not RecruitingNCT05103631
What this trial is testing

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

Who this might be right for
Liver Cell CarcinomaSolid TumorWilms Tumor+5 more
Baylor College of Medicine 12
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Early research (Phase 1)Ended earlyNCT04429321
What this trial is testing

Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary

Who this might be right for
Renal Cell CarcinomaRenal Cell Carcinoma Stage IV
Abramson Cancer Center at Penn Medicine 1
Testing effectiveness (Phase 2)Ended earlyNCT00009919
What this trial is testing

SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Study completedNCT00416871
What this trial is testing

Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Centre Leon Berard 220
Testing effectiveness (Phase 2)Study completedNCT04535687
What this trial is testing

Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1
Early research (Phase 1)Study completedNCT01497821
What this trial is testing

AMG 172 First in Human Study in Patients With Kidney Cancer

Who this might be right for
Renal Cell AdenocarcinomaClear Cell Renal CarcinomaClear Cell Renal Cell Carcinoma+1 more
Amgen 37
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableStudy completedNCT02143492
What this trial is testing

Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC

Who this might be right for
Kidney CancerRenal Cell CarcinomaAdvanced Renal Cell Carcinoma
Argos Therapeutics 11
Next Page